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ABSTRACT: Heterotopic ossification (HO) is the abnormal formation of bone in soft tissue. Current diagnostics have low sensitivity or
specificity to incremental progression of mineralization, especially at early time points. Without accurate and reliable early diagnosis
and intervention, HO progression often results in incapacitating conditions of limited range of motion, nerve entrapment, and pain. We
hypothesized that non-invasive near-infrared (NIR) optical imaging can detect HO at early time points and monitor heterotopic bone
turnover longitudinally. C57BL6 mice received an Achilles tenotomy on their left hind limb in combination with a dorsal burn or sham
procedure. A calcium-chelating tetracycline derivative (IRDye 680RD BoneTag) was injected bi-weekly and imaged via NIR to measure
accumulative fluorescence for 11wk and compared to in vivo microCT images. Percent retention of fluorescence was calculated
longitudinally to assess temporal bone resorption. NIR detected HO as early as five days and revealed a temporal response in HO
formation and turnover. MicroCT could not detect HO until 5wk. Confocal microscopy confirmed fluorophore localization to areas of
HO. These findings demonstrate the ability of a near-infrared optical imaging strategy to accurately and reliably detect and monitor
HO in a murine model.  2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 32:1416–1423, 2014.
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Heterotopic ossification (HO) is a debilitating condition
resulting in abnormal formation of bone in soft tissue.
Common causes include trauma, burns, orthopaedic
surgery, traumatic brain injury, or a combination of
these events.1,2 Without accurate and reliable early
diagnosis and intervention, progression often results
in joint contractures, nerve entrapment, and pain.1,2
Resolution of HO requires invasive surgery, leaving
>75% of patients with functional deficits.2
Early intervention combined with common prophy-
lactic treatments such as NSAIDs or single dose
radiation therapy3–6 protects against recurrence of HO
formation, in addition to an easier surgery, quicker,
more effective rehabilitation, and improved viability of
surrounding tissue.7,8 Therefore, the development of a
sensitive diagnostic modality that can detect HO at
early time points would greatly improve clinical care
of HO patients.
Radiographic techniques, including computed tomog-
raphy (CT) and magnetic resonance imaging (MRI),
provide high resolution visualization of late stage HO;
however, they have low sensitivity to incremental pro-
gression of mineralization and difficulty differentiating
HO from surrounding soft tissue, especially early.9–12
Combined MRI and CT aids in the early diagnosis of
HO; however, this relies on a “wait and see” approach to
monitor changes in mineralization over time, which may
be unsuitable for diagnosing cases where progression can
be detrimental.13 CT and MRI can also be time-consum-
ing and expensive, particularly in longitudinal imaging.
Three-phase bone scintigraphy (SPECT) is used for
early HO detection.2 However, presence of inflamma-
tion or callus formation, which commonly accompany
ectopic bone formation, may cause false positives
during normal tissue healing when HO is not present
and a high level of variability.14,15 The absolute
quantification of SPECT signals is complicated by
factors including photon scatter and attenuation, neces-
sitating complex corrective algorithms.16 Ultrasound
can detect HO sooner than conventional radiography,
but cannot distinguish new bone formation from less
mineralized mature bone.17,18
Therefore, the capability to accurately diagnose HO
formation and progression would ensure the greatest
benefit of treatment therapies and minimize complica-
tions from unnecessary prophylaxis. Non-invasive
near-infrared (NIR) fluorescence imaging modalities
have the potential to diagnose bone mineralization and
bone turnover at multiple time points.19 NIR can
achieve high tissue penetration of light and low tissue
autofluorescence within the NIR spectrum20 and allows
for the visualization of multiple contrast agents at
nanomolar levels.21 NIR imaging techniques have been
used to monitor exogenous contrast agents associated
with bone mineralization, resorption, and skeletal drug
delivery in rodent models of development, repair, and
disease,19,22,23 and advanced techniques are currently
being investigated for humans.24
HO is believed to be formed primarily in the context
of endochondral ossification. Currently, animal models
exist for studying HO, but many rely on implantation
of osteogenic cells or media implanted in the soft
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tissue, which is not analogous to the clinical scenario.
Therefore, a mouse model that is similar to the
causation of clinical HO was utilized. This model
involves local tendon damage and systemic inflamma-
tion caused by a burn, which are both common causes
of HO, and results in spontaneous HO formation. 1,25
We evaluated the ability of NIR imaging to noninva-




Seven to eight week old male C57BL6 mice underwent a
unilateral Achilles tenotomy with or without an accompa-
nying dorsal partial thickness burn injury (N¼ 7/group). The
burn injury consisted of immersion of 30% of the mouse
dorsum in a water bath for 18 s (sham¼ 30˚C, burn¼ 60˚C).
This procedure accelerates HO formation at the tenotomy
site.26 HO was then measured longitudinally using NIR
optical imaging and microCT for 11wk. Findings were
confirmed via endpoint histology. All studies were approved
by the University of Michigan Committee on Use and Care of
Animals.
Assessment of Probe Specificity and Distribution
To assess the optimal timing for fluorescent imaging probe
delivery, longitudinal imaging was performed on three
10wk-old female Balb/C mice injected with a cocktail of
IRDye 680RD BoneTag (160nmoles/kg; LI-COR Biosciences,
Lincoln NE) and IRDye 800CW Carboxylate (80nmoles/kg;
LI-COR Biosciences). The former probe is an NIR calcium-
chelating tetracyline derivative with maximum wavelengths
of 675nm absorption and 697 emission. 27 The latter probe is
a spectrally distinct (774 nm absorption/788 nm emission),
non-reactive control dye used to assess non-specific clearance
through the bloodstream and tissues. Mice were imaged as
described below at baseline, prior to injection, and subse-
quently at 5min and 2, 6, 12, 24, 48, and 72h to assess
BoneTag binding versus non-specific vascular perfusion at
the proximal tibia.
In Vivo Near-Infrared Optical Imaging of Heterotopic
Ossification
At 5 days, and every 2wk following for 11wk, mice received
80nmole/kg of IRDye 680RD BoneTag (LI-COR Biosciences)
in 100mL PBS via tail-vein injection while anesthetized. This
contrast agent is an NIR calcium-chelating tetracycline
derivative, with maximum wavelengths of 675nm absorption
and 697nm emission.27 Prior to each injection, mice were
imaged using a multi-spectral acquisition system (Pearl
Impulse, LI-COR Biosciences, 685 nm excitation) to quantify
baseline levels of tissue fluorescence. Mice were subsequently
imaged 24hrs post-injection to quantify the amount of
newly-bound BoneTag fluorophore at each time point.
HO was assessed by measuring total fluorescence of
BoneTag in regions of interest of the posterior calcaneus and
mid-tibia. Regions of interest were identified on brightfield
images and then overlaid on fluorescence images to quantify
the total fluorescence for each specimen, as a sum of the
fluorescence in the posterior calcaneus and mid-tibia. The
amount of fluorescence present before injection was sub-
tracted from the amount measured 24hrs after injection to
quantify the amount of probe delivered for each 2wk time
period. The Accumulative Fluorescence through the duration
of the study was calculated by summing the fluorescence at
each time point and used as a surrogate marker for how
much total heterotopic bone was formed (Equation 1). To
assess temporal resorptive activity, Percent Retention of the
BoneTag fluorophore during each 2wk period was calculated
by subtracting the amount of retained fluorophore measured
in the pre-injection image from the post-injection image of




þ    þ ðPostinjection PreinjectionÞN
ð1Þ
Percent Retention N to Nþ1 ¼ PostinjectionN  PreinjectionNþ1
ð2Þ
In Vivo MicroCT
While still anesthetized, mice were imaged using microCT
(GE Healthcare Pre-Clinical Imaging, London, Ontario).
Images were reconstructed at an isotropic voxel size of 45mm
and calibrated for densitometry. Regions of interest analo-
gous to those used for NIR focused on the distal calcaneus
and mid-tibia and were isolated and assessed (MicroView
v2.2, GE Healthcare Pre-Clinical Imaging) to measure HO
volume independent of pre-existing native bone. A global
threshold of 1000 Hounsfield Units was applied for assess-
ment.
Ex Vivo Near-Infrared Optical Imaging
At 11wk, mice were euthanized, and tibiae and calcanei
were removed together, minimally dissected, and imaged by
NIR (Pearl Impulse, LI-COR Biosciences). Regions of inter-
ests akin to those used to assess the in vivo NIR images were
used to measure HO ex vivo.
Ex Vivo MicroCT
Tibia and calcanei were then analyzed by microCT (eXplore
Locus SP, GE Healthcare Pre-Clinical Imaging). Specimens
were immersed in water and scanned two at a time using the
Parker method (180˚ plus a 20˚ fan angle) of rotation at
80kVp and 80mA with added filtration in the form of both an
acrylic beam flattener and a 0.02 inch aluminum filter.
Images were reconstructed at 18mm voxel size and calibrated
for densitometry.
Histology
To examine probe localization within the HO sites, tibiae and
calcanei were fixed in 10% NBF for 24hrs, dehydrated in
70% EtOH, processed, and embedded in PMMA as previously
described.28 Thick sections were cut (EXAKT 300 CP,
EXAKT Technologies, Inc. Norerstedt, Germany) and pol-
ished to a thickness of 250mm (EXAKT 400 Micro Grinding
System, EXAKT Technologies). Images of probe localization
in HO and in normal cortical and trabecular bone were taken
using confocal microscopy (Leica Upright SP5X Confocal
Microscope, Leica Microsystems, Wetzlar, Germany) with
10x objectives. Images from 3 consecutive sections were
taken to confirm consistency. The same sections were then
stained with toluidine blue to confirm tissue general tissue
features.29
OPTICAL IMAGING OF HETEROTOPIC OSSIFICATION 1417
JOURNAL OF ORTHOPAEDIC RESEARCH NOVEMBER 2014
Data Analysis
HO progression and probe resorption over the 11wk time
course measured by accumulative fluorescence and percent
of fluorophore retention and bone volume measured by
microCT were assessed by mixed model and within-sample
repeated measures ANOVA followed by Bonferroni post-hoc
tests. A linear regression was conducted to determine ability
of microCT bone volume to predict in-vivo NIR fluorescence
accumulation. Data are presented as mean std dev. All
data were analyzed using IBM SPSS Statistics V.21 (SPSS,




Vascular perfusion of BoneTag680 and the carboxylat-
ed control probe was rapid, with significant proximal
tibial signal within 5min of injection (Fig. 1). IRDye
800CW signal subsequently declined between 5min
and 12h, demonstrating rapid vascular clearance. In
contrast, BoneTag signal peaked at 2h, and then
gradually declined to stable levels by 24hrs post-
injection, where signal remains 70 times that of the
carboxylated control (Fig. 1). These findings indicated
24h as an optimal time for imaging post-injection.
In Vivo NIR Optical Imaging
In vivo NIR imaging revealed ectopic bone formation
as early as 5 days in tenotomized limbs of burn and
sham groups as compared to their contralateral con-
trols, which progressed temporally at each time point
(Fig. 2A,B). A significant difference in ossification
between the 60˚ burn and 30˚ sham groups was
observed at 5wk, with a trend towards differences at
7, 9, and 11wk (p<0.10). Progression of HO was
evident in the temporal NIR imaging sequence
(Fig. 3), where both calcaneal and mid-soleus HO
could be seen early on in the 60˚ group, and later in
the 30˚ animals. Non-specific probe accumulation was
evident in contralateral limbs of mice from both groups
in the ankle, foot, and proximal tibial growth plates,
with background levels well below those of operated
limbs.
In addition to newly forming HO, local bone resorp-
tion was also temporal in nature. There was a
decrease in fluorophore retention between 5days and
3wk compared to percent retention from 5wk and
beyond (Fig. 4A). This decrease retention is suggestive
of an increase in resorptive activity between 5days
and 3wk compared to 5wk and beyond in the tenotom-
ized limbs. Non-operated control limbs showed stable
fluorophore retention, reflecting stability of turnover
at non-HO sites (Fig. 4B).
In Vivo MicroCT
In vivo microCT was unable to detect HO until 5wk,
beyond which temporal progression of HO was consis-
tent with that observed by in vivo NIR imaging
(Fig. 2C). The response to the systemic inflammatory
burn also produced an increase in HO bone volume at
5, 7, and 9wk as compared to the tenotomy only group.
Beyond 5wk, microCT was predictive of accumulative
fluorescence as a measurement of HO (r2¼0.63,
p< 0.0005, Fig. 2D).
Ex Vivo Imaging and Histologic Assessment
High resolution ex vivo NIR optical imaging confirmed
high probe accumulation at the posterior calcaneus
and mid-soleus, consistent with ex vivo microCT scans
(Fig. 5). Confocal microscopy revealed BoneTag probe
within mature cortical bone and in areas of HO. Mid-
tibial HO was woven and unorganized in nature
(Fig. 6A-C) in contrast to the well-organized sequential
labeling of the tibia (Fig. 6D, E). Toluidine blue
staining confirmed mineralized bone tissue distinct
from surrounding soft tissues.
Microscopic imaging of the bound BoneTag fluoro-
phore to the HO posterior to the calcaneous was highly
unorganized and trabecular in nature (Fig. 6F, H).
Consistently across specimens, a “shell” of mature
bone with trabecular-like woven bone inside was
observed (Fig. 6F, G). These trabecular spicules were
labeled with one or two distinct lines of BoneTag,
reflecting the high turnover at this site. Conversely,
fluorescence labeling of the posterior calcaneus was
well organized and sequential in nature (Fig. 6J).
Toluidine blue staining showed the distinction be-
tween mineralized bone tissue, surrounding soft tis-
sues, and non-mineralized tissue within the HO
regions of interest (Fig. 6G, I, K).
DISCUSSION
In a mouse model of HO, longitudinal NIR imaging
revealed increased accumulative fluorescence in teno-
Figure 1. Time course of BoneTag distribution at the proximal
tibia. Mice injected with BoneTag680 or a carboxylated control
probe demonstrated early vascular perfusion of both imaging
agents. BoneTag680 was retained specifically at skeletal sites,
while the control probe was rapidly cleared through the vascula-
ture after 5min and virtually absent at 24h. Inset: Probe
fluorescence over initial 2h magnified for clarity.
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tomized limbs at sites of extraskeletal bone formation
compared to contralateral control limbs. Furthermore,
NIR could differentiate the acceleration of HO in mice
receiving an isolated dorsal burn at 5wk post-injury.
Interestingly, NIR could detect heterotopic mineraliza-
tion earlier than microCT, which even at a resolution
20X greater than that used clinically21 was unable to
detect HO formation above mineralized thresholds
Figure 2. (A) Accumulative fluorescence in limbs subject to Achilles tenotomy was greater than contralateral controls in both (A) 30˚
and (B) 60˚ burn groups (p< 0.05 tenotomy vs. control). In both tenotomy groups, accumulative fluorescence significantly increased in
a temporal manner. (B) Burn significantly accelerated HO by 5wk over tenotomy alone (# p<0.05 tenotomyþ burn (B) versus tenotomy
(A) with a trend toward continuing differences at 7, 9, and 11wk (p< 0.10). (C) Heterotopic ossification was not detected by microCT
until 5wk. (D) Once detected, microCT was highly predictive of accumulative fluorescence; R2¼0.63, p<0.0005.
Figure 3. Temporal progression of heterotopic ossification was visualized by NIR imaging for (A) 30˚ tenotomy limbs and (B)
tenotomy plus burn limbs. (C) Intact contralateral limbs from the burn group, which did not form HO are shown for comparison.
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until 5wk in our model. This inability of radiography
to detect HO at early time points is analogous to the
clinical setting, where radiographic techniques are of
limited utility in the early detection of HO formation.
These detection limits could likely be improved with
increased radiographic image resolution, but this may
require greater associated radiation exposure and
longer scan times, limiting the potential gains in
image fidelity. Here, NIR could detect small amounts
of early mineralization prior to our CT measures,
consistent with our prior work using non-invasive
Raman spectroscopy to detect early mineralization
changes associated with HO in this same model.26
Together, these findings suggest a benefit for optical
technologies at assessing either chemical changes or
focal mineralization through exogenous contrast
agents associated with HO.
Fluorochrome-labeled biopsies have been used to
monitor heterotopic ossification progression histolo-
gy.30 By using a tetracycline derivative with wave-
lengths shifted to the near-infrared, we have expanded
the ability to detect HO to in vivo by imaging at
wavelengths that have increased tissue penetration in
the context of reduced background autofluorescence.20
Confocal microscopy validated our in vivo observa-
tions. The NIR probe localized to areas of HO, but was
also distributed throughout the existing ossified tissue.
Labeling of HO revealed a woven and disorganized
bone appearance, while neighboring mid-tibial and
posterior calcaneal bone demonstrated a well-orga-
nized lamellar bone with multiple sequential labels,
reflecting the continued growth of these animals over
the entire 11wk. This non-HO labeling was apparent
Figure 4. (A) Percent retention of fluorescence was signifi-
cantly lower from 5days to 3wk compared to the 5–7, 7–9, and
9–11wk time points (, ^¼p< 0.05 for tenotomized and teno-
tomizedþburn groups respectively), indicating increased local-
ized resorptive activity in both the tenotomy and tenotomyþ
burn groups until 3wk, which normalizes by 5wk. (B) This is in
contrast to the contralateral limbs of both groups, which did not
show any changes in fluorophore retention over time course.
Figure 5. Ex vivo near-infrared (A) and microCT (B) images taken at 11wk confirm the formation of mid-tibial HO, as well as HO
formed around and on top of the posterior calcaneus. Formation of HO in the mid-tibia as well as the posterior-calcaneus was observed
in all mice by cessation of observation at 11wk time point.
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in contralateral limbs, where fluorophore accumulated
due to the animal growth, but remained less than
tenotomy limbs as HO progressed.
Currently, the underlying molecular mechanisms
responsible for HO are not well understood, but an
increase in BMP levels is thought to cause mesenchy-
mal stem cells to differentiate down osteogenic and
chondrogenic lineages, thus stimulating endochondral
ossification at non-bone sites, dependent on the native
tissue. In addition to the progressive mineralization
found at our HO sites, we observed dynamic turnover
of HO at early time points. Previous work showed that
HO results from increased inflammation in this mod-
el,26,31 and in the present study we found HO to be
accelerated when tenotomy was accompanied by burn
at sites distant from the tenotomy injury. Few studies
have looked at the resorptive activity associated with
HO,32 and due to the longitudinal nature of our study,
we were unable to assess histology or endpoint imag-
ing at early time points. Interestingly, the inflammato-
Figure 6. (A) confocal microscopy of mid-tibia region confirmed probe binding in regions of HO (B) as well as pre-existing cortical
bone (D). Subsequent staining with toluidine blue confirmed HE (C) and cortical bone (E) phenotype. Confocal image of posterior
calcaneous and corresponding (G) toluidine blue-stained section. (H,I): Unorganized HO formed on top of well-organized cortical bone
(J,K). Scale bar¼ 100mm.
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ry markers IL-6 and TNF-a, which are both elevated
at early time points in HO,31,33 were also shown to
synergistically increase osteoclast differentiation and
resorption.34 The early loss of fluorescence in limbs
subject to tenotomy, but not contralateral controls,
may reflect an early turnover phenotype in this model
that subsequently stabilizes as HO progresses. Fur-
ther investigation into the physiological mechanisms
underlying this dynamic turnover may provide insight
into novel treatment therapies designed to interrupt
this early remodeling process. Significantly, the early
detection potential for this model allows for further
investigations into both the formation and resorption
mechanisms responsible for HO, which could lend
insight into potential future therapy options.
Previous studies using this contrast agent demon-
strated a linear increase in fluorescence signal with
increasing doses in vivo and in vitro without signal
saturation27, suggesting ability to quantify HO, partic-
ularly at the low levels of mineralization when HO
identification is most challenging. Translation to the
clinic may require alternative visualization approa-
ches, since traditional planar fluorescence imaging of
NIR agents is restricted to several millimeters of
tissue depth due to light penetration limitations and
non-linear relationships between signal strength,
depth of probe, and optical properties of the tissue.35
Therefore, the use of handheld devices relying on
planar illumination and imaging may be limited to
sites nearest the skin surface, or during intraoperative
procedures where NIR-guided imaging for resection of
mineralization could be used in an open surgical
site.36 Similarly, advances in catheter-based imaging
for arthroscopic/endoscopic diagnosis of HO formation
could allow a clinician to bring the excitation source
and detection hardware to sites of interest in a
minimally invasive manner.37 Lastly, photoacoustic
imaging, which relies on ultrasound detection of
thermal expansion events associated with fluorophore
excitation, reduces the susceptibility to penetration
depth artifacts, and recent work showed resolution
detection up to 0.1mm in pre-clinical models.38 Using
any of these techniques, the patient would be injected
with a bone-specific fluorophore, and then imaged for
easier, earlier resection of the HO, bypassing the
tissue penetration limitations associated with optical
imaging. In summary, our findings suggest NIR
contrast agents may be beneficial to the early detec-
tion of HO formation and subsequent monitoring of
HO turnover, and may provide a sensitive and reliable
approach to detection and monitoring of HO progres-
sion and therapy.
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